Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 11, 2017

Primary Completion Date

June 15, 2021

Study Completion Date

June 15, 2021

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT

Given IV The experimental 18F-FLT-PET/CT is required to be completed before initiation of chemotherapy. Labs and correlative radiology, as directed per clinical care, are required within 30 days prior to 18F-FLT-PET/CT; and 18F-FDG-PET/CT is required within 30 days before the 18F-FLT-PET/CT. Follow-up will comprise 24 months of standard practice treatment and follow up.

PROCEDURE

Computed Tomography

Undergo PET/CT

PROCEDURE

Positron Emission Tomography

Undergo PET/CT

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03318497 - Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma | Biotech Hunter | Biotech Hunter